Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer
Synergy Health Partners, a leader in specialized hospital staffing and management models that improve access […]
Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer
Scholar Rock, a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases […]
Halozyme Appoints Barbara Duncan to its Board of Directors
Halozyme Therapeutics today announced the appointment of Barbara Duncan to its Board of Directors. Ms. Duncan brings more […]
Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer
Cambia Health Solutions has named Mihir Patel, Pharm.D., RPh, as its Chief Pharmacy Officer. In this […]
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first-in-class therapeutics for highly aggressive cancers, […]
enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer
enGene, a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]
Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Cardiff Oncology, a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to […]
Poseida Therapeutics Announces Board Change
Poseida Therapeutics, a clinical-stage cell and gene therapy company advancing a new class of treatments […]
AviadoBio Announces Appointment of Jeff Goater as Chair of the Board of Directors
AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines […]
Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, as Chief Medical Officer
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more